Advances in Clinical Chemistry, Volume 44
Elsevier, Jul 10, 2007 - Medical - 312 pages
Volume forty-four of the Advances in Clinical Chemistry series contains review articles of wide interest to clinical laboratory scientists and diagnostic adventurers. Articles in this volume cover such topics as Caspases in Myocardial Infarction; Deamidated Gliadin Peptides as Targets for Celiac Disease Specific Antibodies; Urokinase Receptor Variants in Tissue and Body Fluids; Proteomics in Cancer; Paraneoplastic Neurological Syndromes and Oncnerual Antibodies: Clinical and Immunological Aspects; Pathophysiologic Mechanisms of Angiogenesis; Bikunin (Urinary Trypsin Inhibitor): Structure, Biological Relevance and Measurement; and Gene Expression Assays.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Deamidated Gliadin Peptides as Targets for Celiac DiseaseSpecific Antibodies
Urokinase Receptor Variants in Tissue and Body Fluids
Proteomics in Cancer
Clinical and Immunological Aspects
Other editions - View all
2D‐PAGE angiogenesis angiogenic angiogenic factors antigen apoptosis apoptotic assay associated autoantibodies aVected binding Biochem Biol Chem biomarkers blood brain breast cancer cancer cells cancer patients carcinoma cardiomyocytes caspase caspase inhibitor caspase‐3 CD patients celiac disease cell death cell lines cell surface cellular cleavage cleaved Clin clinical deamidated detection diagnostic disorders diVerent diVerentially expressed domain ELISA endothelial cells enzyme epitope eVect function gene expression profile gliadin gliadin antibodies gliadin peptides Hoyer‐Hansen human identified immune Immunol inflammation inflammatory inhibition kinase levels lung cancer mAbs malignant markers membrane mice microarray mitochondrial molecular molecules myocardial neuronal neuropathy neutrophil normal onconeural antibodies paraneoplastic cerebellar degeneration paraneoplastic neurological pathways peptides plasma plasmin prognostic prostate protein proteomic reperfusion response role samples SCLC sequence serum signaling specific suPAR symptoms syndrome target therapy tissue transglutaminase tumor uPAR uPAR(I uPAR(I–III urokinase receptor urokinase‐type plasminogen activator vascular endothelial growth VEGF